Amerisource Recalls Mispackaged Adderall XR 20 mg Extended-Release Capsules
Amerisource Health Services is recalling 666 cartons of Adderall XR 20 mg capsules due to unit dose mispackaging where blister cavities may contain more than one capsule.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves unit dose mispackaging which could lead to dosing errors, but no specific injuries or illnesses are reported in the source text.
Plain-English summary
Amerisource Health Services is recalling 666 cartons of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mixed Salts of a Single-Entity Amphetamine Product) Extended-Release Capsules, CII 20 mg. The affected product is packaged and distributed by American Health Packaging in Columbus, Ohio, and is identified by NDC 68084-832-25 for cartons and NDC 68084-832-95 for blisters.
The recall is being conducted because of unit dose mispackaging, where blister cavities may contain more than one tablet or capsule. The affected lots are 152325 (exp. 12/31/16) and 154834 (exp. 5/31/17). The product was distributed nationwide.
Healthcare providers and patients should check their inventory for these specific lot numbers and expiration dates. If the product is found, it should be returned to the distributor or disposed of according to local regulations. Consumers should consult their healthcare provider if they have concerns about their medication.
The recalled product
- Product
- Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mixed Salts of a Single-Entity Amphetamine Product) Extended-Release Capsules, CII 20 mg, 30 UD Capsules (5 x 6), Rx, Packaged and Distributed by: American Health
- Manufacturer
- Amerisource Health Services
- Category
- Drug — Controlled Substance
- Hazard
- Affected units
- 666
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot 152325
- exp. 12/31/16
- lot 154834
- exp. 5/31/17
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by Amerisource Health Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Amerisource Health Services
See all →- HighAmerisource Recalls Paroxetine Tablets Due to Foreign Object Presence
FDA (Drugs) · 2017-11-29
- LowAmerisource Recalls Enalapril Maleate Tablets Due to Stability Failures
FDA (Drugs) · 2017-11-22
- ModerateAmerisource Recalls Glipizide Extended-Release Tablets Due to Dissolution Failure
FDA (Drugs) · 2017-03-22
- ModerateCyclosporine Capsules Recalled for Impurity Specification Failures
FDA (Drugs) · 2017-03-08
- ModerateAHP Nifedipine Capsules Recalled for Presence of Foreign Tablets
FDA (Drugs) · 2016-11-30
Same hazard · mispackaging
See all →- HighRitz peanut butter cracker sandwiches recalled over undeclared peanut from mispackaging
FDA (Devices) · 2025-12-31
- HighCasa Mamita churro bites recalled after cheese stick found in bag
FDA (Food) · 2025-08-06
- HighRitz peanut butter cracker 20 count cartons recalled over undeclared peanut
FDA (Food) · 2025-07-30
- HighRitz peanut butter cracker 40 count cartons recalled over undeclared peanut
FDA (Food) · 2025-07-30
- HighRitz cracker sandwich variety packs recalled over undeclared peanut from mispackaging
FDA (Food) · 2025-07-30